Cite
HARVARD Citation
Flynn, M. et al. (2019). Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma. Hepatology. 69 (5), pp. 2258-2270. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Flynn, M. et al. (2019). Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma. Hepatology. 69 (5), pp. 2258-2270. [Online].